Sigma Labs Reports Second Quarter 2019 Financial Results

Condensed Statements of Cash Flows
(Unaudited)

	Six Months Ended
	June 30, 2019			June 30, 2018
OPERATING ACTIVITIES
Net Loss	$	(3,077,603	)	$	(2,559,680	)
Adjustments to reconcile Net Loss to Net Cash used in operating activities:
Noncash Expenses:
Depreciation and Amortization		97,586			95,574
Stock Based Compensation		474,150			594,915
Loss on Write-off of Asset		-			36,733
Change in assets and liabilities:
Accounts Receivable		818			41,028
Interest Receivable		27,038			38,139
Inventory		(330,340	)		47,100
Prepaid Assets		(1,463	)		(9,613	)
Accounts Payable		150,567			187,495
Deferred Revenue		27,275			34,026
Accrued Expenses		(105,678	)		21,764
NET CASH USED IN OPERATING ACTIVITIES		(2,737,650	)		(1,472,519	)

INVESTING ACTIVITIES
Purchase of Property and Equipment		(23,796	)		(41,968	)
Purchase of Intangible Assets		(107,124	)		(60,147	)
Payment Received from Notes Receivable		15,000			632,197
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES		(115,920	)		530,082

FINANCING ACTIVITIES
Proceeds from issuance of Series B Preferred & Warrants		-			1,000,000
Proceeds from issuance of Series C Preferred & Warrants		-			350,000
Gross Proceeds from issuance of Common Stock and Warrants		2,521,220			2,040,100
Less Offering Costs		(326,890	)		(443,700	)
Proceeds from exercise of Warrants		75,848			-
NET CASH PROVIDED BY FINANCING ACTIVITIES		2,270,178			2,946,400

NET CHANGE IN CASH FOR PERIOD		(583,392	)		2,003,963

CASH AT BEGINNING OF PERIOD		1,279,782			1,515,674

CASH AT END OF PERIOD	$	696,390		$	3,519,637

Supplemental Disclosures:
Noncash investing and financing activities disclosure:
Conversion of Convertible Debt for Stock	$	-			(50,000	)
Other noncash operating activities disclosure:
Issuance of Common Stock for services	$	153,000		$	256,264
Disclosure of cash paid for:
Interest	$	2,514		$	8,761
Income Taxes	$	-		$	-

Primary Logo

« Previous Page 1 | 2 | 3 | 4